Transfusion Medicine Market, 2019-2023: Supplier Shares by Product and Country, Emerging Technologies, Strategic Profiles of Leading Suppliers
This 114-page report provides assessments of such technologies as molecular diagnostics, monoclonal and polyclonal antibodies, immunoassays, microtitration plates, IT, lasers, synthetic red cell substitutes, genetically engineered blood components, blood preservation, autologous blood transfusion/freezing and their potential applications for transfusion diagnostic.
The report also presents strategic assessments of current and emerging suppliers of transfusion diagnostic products, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.
Current and Emerging Technologies
Molecular Diagnostics
a. Overview
b. NAT
Monoclonal and Polyclonal Antibodies
Immunoassays
a. Technological Principle
b. Chemiluminescence
c. Enzyme Immunoassays (EIA)
- Overview
- ELISA
- EMIT
- Electrochemical
d. Radioimmunoassays (RIA)
e. Immunoprecipitation
f. Affinity Chromatography
Microtitration Plates
IT and Automation
Lasers
Robotics
Synthetic Red Cell Substitutes
Genetically Engineered Blood Components
a. Albumin
b. Factor VIII
c. Alpha-2 Antiplasmin
d. Antithrombin III
e. Factor IX
f. Von Willebrands Factor
g. Fibrinogen
h. t-PA
Blood Preservation
Autologous Blood Transfusion/Freezing
Competitive Profiles
- Abbott
- Beckman Coulter/Danaher
- Becton Dickinson
- Biokit
- BioMerieux
- Bio-Rad
- CellMark Forensics/LabCorp
- Diagast
- DiaSorin
- Fujirebio
- Grifols
- Hologic/Gen-Probe
- Immucor
- Ortho-Clinical Diagnostics
- Proteome Sciences
- Quest Diagnostics
- Roche
- Siemens
- Tecan
- Thermo Fisher
2020 Denmark Transfusion Diagnostics Market for 40 Immunohematology and NAT Assays: Supplier Shares and Strategies, Volume and Sales Forecasts, Emerging Technologies, Instrumentation and Opportunities
This new report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities during the next five years, and assist industry executives in developing effective
View Report2020 Czech Republic Transfusion Diagnostics Market for 40 Immunohematology and NAT Assays: Supplier Shares and Strategies, Volume and Sales Forecasts, Emerging Technologies, Instrumentation and Opportunities
This new report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities during the next five years, and assist industry executives in developing effective
View ReportGlobal Immunohematology and NAT Screening: US, Europe, Japan--Transfusion Medicine Analyzers and Reagents--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review, Emerging Opportunities
This new seven-country strategic analysis was prepared in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities and assist industry executives in developing effective business,
View ReportGlobal Immunohematology and NAT Screening Market, 2019-2023: Transfusion Medicine Analyzers and Reagents--Supplier Shares and Strategies, Country Segment Forecasts, Technology Trends, Emerging Opportunities
This new seven-country strategic analysis was prepared by in order to help current suppliers and potential market entrants identify and evaluate emerging opportunities and assist industry executives in developing
View ReportFill The Form For Sample Request